Skip to main content

and
  1. Article

    Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients

    Human infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) and there is no cure currently. The 3CL protease (3CLpro) is a highly conserved prot...

    Hai-xia Su, Sheng Yao, Wen-feng Zhao, Min-jun Li, Jia Liu in Acta Pharmacologica Sinica (2020)

  2. No Access

    Article

    The inhibitory mechanism of aurintricarboxylic acid targeting serine/threonine phosphatase Stp1 in Staphylococcus aureus: insights from molecular dynamics simulations

    Serine/threonine phosphatase (Stp1) is a member of the bacterial Mg2+- or Mn2+- dependent protein phosphatase/protein phosphatase 2C family, which is involved in the regulation of Staphylococcus aureus virulence....

    Ting-ting Liu, Teng Yang, Mei-na Gao, Kai-xian Chen in Acta Pharmacologica Sinica (2019)

  3. Article

    Conformation and dynamics of the C-terminal region in human phosphoglycerate mutase 1

    Phosphoglycerate mutase 1 (PGAM1), an important enzyme in glycolysis, is overexpressed in a number of human cancers, thus has been proposed as a promising metabolic target for cancer treatments. The C-terminal...

    Shi-en Liu, Jun-chi Hu, Hao Zhang, Pan Xu, Wei Wan in Acta Pharmacologica Sinica (2017)

  4. Article

    Pharmacophore-based virtual screening versus docking-based virtual screening: a benchmark comparison against eight targets

    This study was conducted to compare the efficiencies of two virtual screening approaches, pharmacophore-based virtual screening (PBVS) and docking-based virtual screening (DBVS) methods.

    Zhi Chen, Hong-lin Li, Qi-jun Zhang, **ao-guang Bao in Acta Pharmacologica Sinica (2009)

  5. Article

    Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/release

    To investigate methods for identifying specific cyclophilin D (CypD) inhibitors derived from quinoxaline, thus develo** possible lead compounds to inhibit mitochondrial permeability transition (MPT) pore ope...

    Hong-xia Guo, Feng Wang, Kun-qian Yu, **g Chen, Dong-lu Bai in Acta Pharmacologica Sinica (2005)